GFAP and dementia: The aim of this study was to explore the association of kidney function with risk of incident AD or dementia diagnosis within 17 years and with the dementia-related blood biomarkers NfL, p-tau181, and glial fibrillary acidic protein (GFAP) in a prospective community-based cohort study.